Abstract
Electroconvulsive treatment (ECT) of mice, once daily for 7 days, significantly reduced the stimulation of motor activity induced by the selective dopamine (DA) D1-receptor agonist SKF 38393 (15 mg/kg IP), but significantly increased the motor stimulation by the unselective DA-receptor agonist apomorphine (1.5 mg/kg IP) in reserpinetreated (10 mg/kg IP) mice, when compared to control mice, receiving sham ECT. The results provide a functional correlate to previously observed ECT-induced down-regulation of D1 receptor sites in DA-rich regions of the rodent brain. Such an effect may be significant for clinical actions of ECT in affective disorders and, possibly, in Parkinson's disease.
This is a preview of subscription content, log in via an institution to check access.
References
Balldin JS, Edén S, Granerus A-K, Modigh K, Svanborg A, Wålinder J, Wallin L (1980) Electroconvulsive therapy in Parkinson's syndrome with “on-off” phenomenon. J Neural Transm 47:11–21
Bergström DA, Kellar KJ (1979) Effect of electroconvulsive shock on monoaminergic receptor binding sites in rat brain. Nature (London) 278:464–466
Braun AR, Chase TN (1988) Behavioural effects of chronic exposure to selective D1 and D2 dopamine receptor agonists. Eur J Pharmacol 147:441–451
Clark D, White FJ (1987) Review: D1 dopamine receptor — the search for a function: a critical evaluation of the D1D2 dopamine receptor classification and its functional implications. Synapse 1:347–388
Delini-Stula A, Vassout A (1979) Modulation of dopamine-mediated behavioural responses by antidepressants. Effect of single and repeated treatment. Eur J Pharmacol 58:443–451
Evans JPM, Graham-Smith DG, Green AR, Tordoff AFC (1976) Electroconvulsive shock increases the behavioural responses of rats to brain 5-hydroxytryptamine stimulation and central nervous stimulant drugs. Br J Pharmacol 56:193–199
Fink M (1979) Convulsive therapy: Therapy and practice. Raven Press, New York
Green AR (1988) The mechanism of action of antidepressant treatments: Basic aspects. Pharmacopsychiatry 21:3–5
Green AR, Heal DJ, Grahame-Smith DG (1977) Further observations on the effect of repeated electroconvulsive shock on the behavioural responses of rats produced by increases in the functional activity of brain 5-hydroxytryptamine and dopamine. Psychopharmacology 52:195–200
Klimek V, Nielsen M (1987) Chronic treatment with antidepressants decreases the number of [H3] SCH 23390 binding sites in the rat striatum and limbic system. Eur J Pharmacol 139:163–169
Koob GF, Le HT, Creese (1987) The D1 dopamine receptor antagonist SCH 23390 increases cocain self-administration in the rat. Neurosci Lett 79:315–320
Lerer B (1984) ECT: basic mechanisms. In: Lerer B, Weiner RD, Belmaker H (eds) Biological psychiatry — new prospects. John Libbey, p 183
Modigh K (1975) Electroconvulsive shock and postsynaptic catecholamine effects: Increased psychomotor stimulant action of apomorphine and clonidine in reserpine-pretreated mice by repeated ECT. J Neural Trans 36:19–32
Modigh K (1978) Correlation between clinical effects of various antidepressant treatments and their effects on monoaminergic receptors in the brain. In: Deniker P, Radouco-Thomas C, Villeneuve A (eds) Proc Tenth Congr of the CINP, Neuropsychopharmacology. Pergamon Press, Oxford New York
Nelson LR, Ellison G (1978) Enhanced stereotypies after repeated injections but not continuous amphetamine. Neuropharmacology 17:1081–1084
Spyraki C, Fibiger HC (1981) Behavioural evidence for supersensitivity of postsynaptic dopamine receptors in the mesolimbic system after chronic administration of desipramine. Eur J Pharmacol 74:195–206
Vetulani J (1986) Neurochemical effects of ECT. In: Shagass C, Josiassen RC, Bridger WH, Weiss KJ, Stoff D, Simpson GM (eds) Biological psychiatry. Elsevier/North Holland Biomedical Press, Amsterdam, p 865
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hao, X.Z., Mathé, A.A., Mathé, J.M. et al. Electroconvulsive treatment attenuates behavioral response to SKF 38393 in reserpine-treated mice. Psychopharmacology 100, 135–137 (1990). https://doi.org/10.1007/BF02245805
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02245805